OncoSolutions, spun out of research conducted at the University of Akron, develops a robotic platform and aqueous polymeric system to generate 3D tumor models for rapid, high throughput drug screening. The company's goal is to reduce the failure rate of cancer drugs in animal studies through increased effectiveness of their drug screening technology. The technology creates tumor models that can be maintained, drug tested, and analyzed in the microplate they are formed.
